NASDAQ: FEAM5e Advanced Materials Inc Stock
$4.44-0.25 (-5.33%)
Updated Apr 30, 2025
FEAM Price
$4.44
Fair Value Price
-$1.21
Market Cap
$13.33M
52 Week Low
$2.82
52 Week High
$45.89
P/E
-0.18x
P/B
-1.59x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$69.15M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-9.91
Operating Cash Flow
-$24M
Beta
1.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
FEAM Overview
5E Advanced Materials Inc. explores for and develops borates and lithium deposits in Australia and the U.S. Formerly known as American Pacific Borates Ltd., the company was incorporated in 2016 and is headquartered in Houston, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FEAM's potential to beat the market
- FEAM doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
C
FEAM
RankedUnranked of 52
RankedUnranked of 52
Be the first to know about important FEAM news, forecast changes, insider trades & much more!
FEAM News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FEAM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FEAM ($4.44) is overvalued by 466.77% relative to our estimate of its Fair Value price of -$1.21 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
FEAM ($4.44) is not significantly undervalued (466.77%) relative to our estimate of its Fair Value price of -$1.21 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FEAM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FEAM due diligence checks available for Premium users.
Valuation
FEAM fair value
Fair Value of FEAM stock based on Discounted Cash Flow (DCF)
Price
$4.44
Fair Value
-$1.21
Undervalued by
466.77%
FEAM ($4.44) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FEAM ($4.44) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FEAM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
FEAM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.18x
Industry
28.11x
Market
29.18x
FEAM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-1.59x
Industry
3.2x
FEAM's financial health
Profit margin
Revenue
$0.0
Net Income
-$14.3M
Profit Margin
0%
FEAM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$74.8M
Liabilities
$83.2M
Debt to equity
-9.91
FEAM's short-term liabilities ($9.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FEAM's long-term liabilities ($73.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FEAM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FEAM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.3M
Investing
-$381.0k
Financing
-$344.0k
FEAM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FEAM vs Specialty Chemical Stocks
5e Advanced Materials Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.